High-Flow Nasal Cannula versus Nasal Continuous Positive Airway Pres-sure in the Management of Respiratory Distress Syndrome

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Pediatric, Child Health Promotion Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Assistant Professor, Department of Pediatric, Child Health Promotion Research Center, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Resident of Neonatology, Department of Pediatric, School of Medicine And Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Although nasal continuous positive airway pressure (NCPAP) in the treatment of respiratory distress syndrome (RDS) is an effective and a non-invasive method, some complications such as septal trauma and intolerance of NCPAP apparatus are occurred. Our objectives are to assess safety and effectiveness of humidified high flow nasal canola (HFNC) as compared to NCPAP in premature neonates with RDS.Methods: Seventy uncomplicated preterm infant (30-35 weeks gestation) with RDS at the neonatal ward of Shahid-Beheshti hospital, Isfahan, Iran, randomized into two groups; Group1 (CPAP) received NCPAP from birth and continued till respiratory distress (RD) and oxygen (O2) need improved and Group 2 (HFNC) received NCPAP for the first 24 hours after birth, then standard HFNC till RD and O2 need improved. Outcomes measures of interest included: death, morbidity such as necrotizing enterocolitis (NEC), patent ductus arteriosus (PDA), (Intraventricular hemorrhage (IVH), chronic lung disease (CLD), pnumothorax, pulmonary hemorrhage, apnea, sepsis, duration of hospitalization, duration of full entral feeding and duration of O2 need. Data entered to computer and outcomes were compared between 2 groups with SPSS software (vesion 11). P values less than 0.05 were considered statistically significant.Findings: There were no differences in death, duration of hospitalization, failure to treatment, duration of improvement of RD, NEC, PDA, IVH, CLD, pnumothorax, pulmonary hemorrhage, apnea, sepsis, duration of hospitalization, duration to reach to full entral feeding between two groups (NCPAP, HFNC). During the study, those on HFNC had more normal examination of nasal mucosa (P < 0.0001). According to neonatal nurses opinions, application of HFNC was easier than NCPAP for neonates (P < 0.0001). Conclusion: HFNC (after received NCPAP for the first 24 hours of birth) is as effective as NCPAP in the management of RDS in premature neonates more than 30 gestational weeks. In addition, HFNC performed easier than NCPAP with maintaining a normal nasal mucosa.

Keywords

References

  1. Martin RJ, Fanaroff AA, Walsh MC. Neonatal- Perinatal medicine. 8th ed. Philadelphia: Mosby; 2005.
  2. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001; (2): CD000510.
  3. Goldsmith JP, Karotkin E. Assisted Ventilation of the Neonate. 4th ed. Philadelphia: Saunders; 2003.
  4. Zaharie G, Ion DA, Schmidt N, Popa M, Kudor-Szabadi L, Zaharie T. [Prophylactic CPAP versus therapeutic CPAP in preterm newborns of 28-32 gestational weeks]. Pneumologia 2008; 57(1): 34-7.
  5. Miksch RM, Armbrust S, Pahnke J, Fusch C. Outcome of very low birthweight infants after introducing a new standard regime with the early use of nasal CPAP. Eur J Pediatr 2008; 167(8): 909-16.
  6. Sandri F, Ancora G, Lanzoni A, Tagliabue P, Colnaghi M, Ventura ML, et al. Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Ed 2004; 89(5):
  7. F394-F398.
  8. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics 2004; 113(6): e560-e563.
  9. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007; 27(7): 422-7.
  10. Ho JJ, Henderson-Smart DJ, Davis PG. Early versus delayed initiation of continuous distending pressure for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2002; (2): CD002975.
  11. Jobe AH, Kramer BW, Moss TJ, Newnham JP, Ikegami M. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res 2002; 52(3): 387-92.
  12. do Nascimento RM, Ferreira AL, Coutinho AC, Santos Verissimo RC. The frequency of nasal injury in newborns due to the use of continuous positive airway pressure with prongs. Rev Lat Am Enfermagem 2009; 17(4): 489-94.
  13. McCoskey L. Nursing Care Guidelines for prevention of nasal breakdown in neonates receiving nasal CPAP. Adv Neonatal Care 2008; 8(2): 116-24.
  14. Locke RG, Wolfson MR, Shaffer TH, Rubenstein SD, Greenspan JS. Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics 1993; 91(1): 135-8.
  15. Saslow JG, Aghai ZH, Nakhla TA, Hart JJ, Lawrysh R, Stahl GE, et al. Work of breathing using high-flow nasal cannula in preterm infants. J Perinatol 2006; 26(8): 476-80.
  16. US Food and Drug Administration [Online] 2007 Aug 10. Available from:URL:http.www.fda.gov/cdrh/pdf4/ k042245.pdf.
  17. Shoemaker MT, Pierce MR, Yoder BA, DiGeronimo RJ. High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study. J Perinatol 2007; 27(2): 85-91.
  18. Sun S, Tero R. Safety and efficacy of the Vapotherm 20001 in the neonatal population. Proceeding of the: AARC International Respiratory Congress; 2004 Dec 4-7; New Orleans, USA.
  19. Ramanathan A, Cayabyab R, Sardesai S, Siassi
  20. B, Seri I, Ramanathan R. High flow nasal cannula use in preterm and term newborns admitted to neonatal intensive care unit: A prospective, observational study. Pediatr Acad Soc 2005; 57(3424).
  21. Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics 2001; 107(5): 1081-3.
  22. Campbell DM, Shah PS, Shah V, Kelly EN. Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants. J Perinatol 2006; 26(9): 546-9.
  23. Update: Public health notification regarding Ralstonia associated with Vapotherm respiratory gas administration devices- United States, 2005. MMWR Morb Mortal wkly Rep 2005; 54(1286): 1287.
  24. Vapotherm website [Online].2007 August 10. Available: from URL:
  25. www.vtherm.com/products/200i.asp.
Journal of Isfahan Medical School
Volume 29, Issue 143 - Serial Number 143
May and June 2011
Pages 761-772

Files

History

  • Receive Date: 12 June 2011
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics